# The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1

> **NCT01400191** · PHASE4 · COMPLETED · sponsor: **University of Southern Denmark** · enrollment: 37 (actual)

## Conditions studied

- Pharmacogenetics of Metformin

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01400191
- **Lead sponsor:** University of Southern Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2015-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01400191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01400191, "The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01400191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*